Vitamin D metabolism and the clinical aspects of measuring metabolites

Annals of Clinical Biochemistry

Volumn 31, Issue 2, 1994, Pages 109-124

  Iqbal, S J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

calcidiol; calcitriol; cell differentiation; cell proliferation

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; VITAMIN D;

CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONCENTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; LIVER; METABOLITE; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ASSAY; REVIEW; RICKETS; SKIN; TISSUE; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN D METABOLISM;

24,25-DIHYDROXYVITAMIN D 3; CALCIFEDIOL; CALCITRIOL; HUMAN; TISSUE DISTRIBUTION; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0028265721     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/000456329403100201     Document Type: Review

References (144)

1. MacLaughlin JA Anderson RR Holick MF Spectral character of sunlight modulates photosynthesis of previtamin D and its photoisomers in human skin. Science 1982; 216: 1001–3
2. Holick MF MacLaughlin JA Clark MB Holick SA Potts JT Anderson RR et al. Photosynthesis of previtamin D in human skin and the physiologic consequences. Science 1980; 210: 203–5
3. Holick MF MacLaughlin JA Doppelt SA Regulation of cutaneous previtamin D3 photosynthesis in man: Skin pigment is not an essential regulator. Science 1981; 211: 590–3
4. Webb AR de Costa B Holick MF Effect of winter solar irradiation on the photochemistry of 7-dehydrocholesterol, its photoisomers, and vitamin D. Photochem Photobiol 1986; 116s: 43s
5. Mawer B The sunshine vitamin. Biol Sci Rev 1992; 3: 2–7
6. Battacharja MM De Luc AF The regulation of rat liver calciferol-25-hydroxylase. J Biol Chem 1973; 248: 2963–73
7. Tucker G III Gaynor RE Houssle MR VitD3 25-hydroxylase: Tissue occurrence and apparent lack of regulation. Arch Biochem Biophys 1973; 155: 47–57
8. Stamp TCB Rand JM Seasonal changes in human plasma levels of 25 hydroxycholecalciferol. Nature 1974; 247: 563–4
9. Fraser DR The physiological economy of vitamin D. Lancet 1983; i: 969–71
10. Fraser DR Kodicek E Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 1970; 228: 764–6
11. Portale AA Halloran BP Murphy MM Morris RC Jr Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 1986; 77: 7–12
12. Fraser DR Regulation of metabolism of metabolism of vitamin D. Physiol Rev 1980; 60: 551–613
13. Holick MF Adams JS Vitamin D metabolism and biological function. In: Avioli LV Krane SM Metabolic Bone Diseases and Clinically Related Disorders. Philadelphia, London: WB Saunders, 1990: 155–95
14. Corvol M Ulman A Garabedian M Specific nuclear uptake of 24,25 dihydroxycholecalciferol a vitamin D3 metabolite active in cartilage. Febs Lett 1980; 116: 273–6
15. Kraft O Offermann G Steldinger R Gawlic D Effect of 1,25(OH)2D3 on 24,25(OH)2D3 on experimental rickets. Res Commun Chem Pathol Pharmacol 1979; 26: 571–83
16. Gray TK Lowe W Lester GE Vitamin D and pregnancy: The maternal foetal metabolism of vitamin D. Endocr Rev 1981; 2: 264–74
17. Bickle DD Nemanic MK Whitney JO Elias PW Neonatal human foreskin keratinocytes produce 1,25 dihydroxyvitamin D3. Biochemistry 1986; 25: 1545–8
18. Howard GA Turner RT Sherrard DJ Baylink DJ Human bone cells in culture metabolize 25 hydroxyvitamin D to 1,25 dihydroxy and 24, 25 dihydroxyvitamin D3. J Biol Chem 1981; 256: 7738–40
19. Adams J Diz MM Gacad MA Regulated expression of sarcoid macrophage 25 hydroxyvitamin D 1-hydroxyvitamin D 1-hydroxylation reaction. In: Norman AW Schaefer K Grigoleit HGG Herrath DV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter 1988; 855–6
20. Pike JW Osteocalcin gene expression as a model for the genomic actions of the vitamin D hormone. In: Normal AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 55–63
21. Barsony J McKay W Marx SJ Receptor mediated rapid actions of steroid hormones: cGMP accumulation and reorganization of receptors. In: Normal AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 351–9
22. Braidman IP Anderson DC Extra-endocrine functions of vitamin D. Clin Endocrinol 1985; 23: 445–60
23. Gensure RC Riggle PC Antrobus SD Fox J Walters MR Are there two classes of 1,25 dihydroxyvitamin D receptors? In: Normal AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 106–7
24. Naveh-Many T Kilav R Silver J Regulation of 1,25 dihydroxyvitamin D, receptor gene expression in the parathyroid gland. In: Normal AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 75–81
25. McDonnel DP Mangelsdorff DJ Pike JW Haussler MR O'Malley BW Molecular cloning of complementary DNA encoding avian receptor for VitD. Science 1987; 235: 1214–17
26. Baker AR McDonnell DP Hughes M Crisp TM Mangelsdorf DJ Haussler MR et al. Cloning and expression of full length CDNA encoding human vitamin D receptor. Proc Nat Acad Sci USA 1988; 85: 3294–8
27. Haussler MR Terpening CM Kom BS Whitfield GK Haussler CA Vitamin D receptors: structure, regulation and function. In: Norman AW Schaefer K Grigoleit HGG Herrath DV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 208–14
28. Raichel H Koefler MD Norman AW The role of vitamin D endocrine system in health & disease. New Eng J Med 1989; 320: 980–91
29. MacLaughlin JA Cantenyl L Holick MK Increase in (Ca2+)i in cultured human keratinocytes by 1,25(0 VitD3 is calcium dependent and coincides with increase in phosphotidylinositol metabolism. In: Norman AW Schaefer K Grigoleit HGG Herrath DV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 340–1
30. Dupret JM Brun P Perret C Lomri N Thomasset M Cuisiner-Gleizs P Transcriptional and post-transcriptional regulator of VitD dependent calcium binding protein gene expression in rat duodenum by 1,25 dihydroxycholecalciferol. J Biol Chem 1987; 262: 16553–7
31. Thomasset M Tenenhouse A Vitamin D dependence of calbindin 9K and calbindin 28K synthesis in various rat tissues. In: Norman AW Schaefer K Grigoleit HGG Herrath DV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 516–17
32. Nemere I Yoshimoto Y Norman AW Calcium transport in perfused duodenum from normal chicks; enhancement within 14 minutes of exposure to 1,25 dihydroxyvitamin D3. Endocrinology 1984; 115: 1476–83
33. Deluca HF Vitamin D: the vitamin and hormone. Fed Proc 1974; 33: 2211–19
34. Kurihara N Ishuzuke S Kiyoki M Haketa Y Ikeda K Kumegawa M Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology 1986; 118: 940–7
35. Pan LC Price PA The effect of transcriptional inhibitors on the bone γ-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells. J Biol Chem 1984; 259: 5844–7
36. Row DW Khean BE Regulation of collagen synthesis in fetal rat calvaria by 1,25 dihydroxyvitamin D3. J Biol Chem 1982; 257: 8009–15
37. Chambers TJ The role of 1,25-dihydroxyvitamin D3 in the generation and regulation of osteoclasts. In: Norman AW Schaefer K Grigoleit HGG Herrath DV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 581–90
38. Henry HL Norman AW Vitamin D metabolism and biological actions. Annu Rev Biochem 1984; 4: 493–520
39. Slatopolsky E Dusso A Brown A James D Vitamin D—The endocrine system and secondary hyperparathyroidism. In: Norman AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 557–861
40. Russell J Lettieri D Sherwood LM Suppression of 1,25 dihydroxy D of transcription of pre-proparathyroid hormone. Endocrinology 1986; 119: 2864–6
41. Rigby WFC The immunobiology of vitamin D. Immunology Today 1988; 9: 54–8
42. Tsoukas CD Provvedini DM Manolaga SC 1,25 dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984; 224: 1438–40
43. Reichel H Koeffler HP Tobler A Norman AW 1α,25 dihydroxy vitamin D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Nat Acad Set USA 1987; 84: 3385–9
44. Tobler A Miller CA Norman AW Koeffler HP 1,25-dihydroxy vitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) post-transcriptionally. J Clin Invest 1988; 81: 1819–23
45. Iho S Takahashi T Kura F Sugiyama H Hoshino T The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol 1986; 236: 4427–31
46. Colston KW New concepts in vitamin D physiology. In: Smith R, ed. Vitamin D: Proceedings of a Closed Workshop. London: Royal Society of Medicine Services Ltd, 1992: 37–19
47. Garland CF Garland FC Shaw KE Cemstock GW Helsing JK Gorham ED Serum 25 vitamin D and colon cancer: eight year prospective study. Lancet 1989; ii: 1176–8
48. Honma Y Hozumi M Abe E et al. 1,25 dihydroxyvitamin D3 and 1 hydroxyvitamin D3 prolonged survival time of mice inoculated with myeloid leukemia cells. Proc Nat Acad Sci USA 1983; 80: 201–4
49. Monker R Normal A Koeffler HP Vitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 1984; 73: 731–8
50. Editorial. Vitamin D: new perspectives. Lancet 1987; i: 1122–3
51. Manolagas SC Vitamin D and its relevance to cancer. Anti Cancer Research 1987; 7: 625–38
52. Reitsma PH Rothbery PG Astrin SM et al. Regulation of myc gene expression in HL60 leukaemia cells by vitamin D metabolite. Nature 1983; 306: 492–5
53. Holick MF Smith E Pincus S Skin as the site of vitamin D synthesis and target tissue for 1,25 dihydroxyvitamin D3. Arch Dermal 1987; 123: 1676–83
54. Kragballe K Efficacy and tolerability of calcipotriol in psoriasis. In: Norman AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 418–23
55. Dunnigan MG Paton JPG Haasig McNicol GW Garner MD Smith CM Late rickets and osteomalacia in Pakistani community in Glasgow. Scot Med J 1962; 7: 159–67
56. Eastwood JB Nisbet JA Colston KW Ang L Flanagan AM Chambers TJ Maxwell JD Plasma 250H Vit D and PTH in detection of osteomalacia in Asian outpatients. Clin Sci 1990; 78: 383–9
57. Iqbal SJ Kaddam I Possible widespread vitamin D deficiency in Asians in Leicester. In: Halloran SP, ed. Proceedings of the National Meeting. London: Association of Clinical Biochemists 1989: 70
58. Willis MR Day RC Philips JB Batene EL Phytic acid and clinical rickets in immigrants. Lancet 1975; i: 771–3
59. Henderson JB Dunnigan MS McIntosh WB Abdul-Motaal AA Gettinby G Glekin BM The importance of limited exposure to UV radiation and dietary factors in aetiology of rickets: A risk factor model. Q J Med 1987; 241: 413–25
60. Clements MR The problem of rickets in UK Asians. J Human Nutr Dietet 1989; 2: 105–16
61. Dunnigan MG Fraser SA McIntosh WB Moseley H Sumner DJ The prevention of vitamin D deficiency in the elderly. Scot Med J 1986; 31: 144–9
62. Lips P Vitamin D nutrition in the elderly: Problems and recommendations. In: Norman AW Bouillon R Thomasset M, eds. Vitamin D. Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 758–64
63. MacLaughlin J Holick MF Aging decreases the capacity of human skin to produce vitamin D. J Clin Invest 1985; 76: 1536–8
64. Anderson I Campbell AER Dunn A Runciman JBM Osteomalacia in elderly women. Scot Med J 1966; 11: 429–35
65. Holick MF Vitamin D requirements for elderly. Clin Nutr 1986; 5: 121–9
66. Turner G Brown RC Silver A Seymour G Woodhead JS Renal insufficiency and secondary hyperparathyroidism in elderly patients. Ann Clin Biochem 1991; 28: 321–6
67. Matsuoko L Ide L Wortsman J Maclaughlin J Holick MF Sunscreens suppress cutaneous vitamin D synthesis. J Clin Endocrinol 1987; 64: 1165–8
68. Webb AR Kline L Holick MF Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin End Metab 1988; 67: 373–8
69. Clark CG Crooks J Dawson AA Mitchell PEG Disordered calcium metabolism after Polya gastrectomy. Lancet 1963; i: 734–8
70. McLennan WJ Hamilton JC Low plasma 25(OH)VitD without osteomalacia. Lancet 1978; i: 1210
71. Hillman LS Hollis B Salomons S Martin L Slatopolsky E McAlister W Haddad J Absorption, dosage and effect on mineral homeostasis of 25 dihydroxycholecalciferol in premature infants. Comparison with 400 and 800iu Vit D2 supplementations. J Paed 1985; 106: 981–9
72. Clements MR Davies M Fraser DR Lumb GA Mawer EB Adams PH Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci 1987; 73: 659–64
73. Dent CE Richers A Rowe DJF Stamp TCB Osteomalacia with anticonvulsant therapy in epilepsy. BMJ 1970; 4: 69–72
74. Corrandino RA Dephaylhydantrin: Direct inhibition of vitamin D3-mediated calcium absorptive mechanism in organic cultured duodenum. Biochem Pharmacol 1976; 25: 863–4
75. Kannis JA Cundy TF Hamdy NAT Renal osteodystrophy. Clin Endocrinol Metab 1988; 2: 193–241
76. Editorial. Renal osteodystrophy. New Eng J Med 1989; 321: 317–18
77. Lucas PA Brown CA Jones CR Woodhead JS Coles GA Reduced 1,25(OH)2VitD3 may be responsible for the development of hyperparathyroidism in early chronic renal failure. Proc Eur Dial Trans Assoc 1985; 22: 1124–8
78. Llach F Massry SG On the mechanism of secondary hyper-parathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 1985; 61: 601–8
79. Woodhead JS Silver AC Ashton JP Brown RC Measurement of circulating parathyroid hormone. Harm Res 1989; 32: 97–100
80. Wilson L Fetsenfeld A Drezner K Llaca F Altered divalent cation metabolism in early renal failure: role of 1,25 dihydroxyvitamin D. Kidney Int 1985; 27: 565–73
81. Brown EM Wilkinson RE Eastman RC Pallotta J Marynick SP Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 1982; 54: 172–9
82. Korkor AB Reduced binding of (3H) 1,25 dihydroxyvitamin D3 in parathyroid glands of patients with renal failure. N Eng J Med 1987; 316: 1573–7
83. Andress DL Norris KC Coburn JW Slatopolsky EA Sherrand DJ Intravenous calcitriol in treatment of refractory osteitis fibrosa of chronic renal failure. N Eng J Med 1989; 32: 274–9
84. Riggs BL Melton LJ III Involutional osteoporosis. N Eng J Med 1986; 314: 1676–86
85. Thakker RV O'Riordan JLH Inherited forms of rickets and osteomalacia. Clin Endocrinol Metab 1988; 2: 157–91
86. Glorieux FH Delvin EE Pseudo-vitamin D deficiency Rickets. In: Norman AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 238–45
87. Leberman UA Inborn errors in vitamin D metabolism—their contribution to the understanding of vitamin D metabolism. In: Norman AW Schaefer K Grigoleit HG Herralt DV eds. Berlin: Walter de Gruyter, 1988: 935–47
88. Hughes MR Malloy PJ Kieback DG et al. Point mutations in the human vitamin D receptor gene associated with hypocalcaemic rickets. Science 1988; 242: 1702–5
89. Malloy PJ Hughes MR Pike JW Feldman D Vitamin D receptor mutations and hereditary 1,25 dihydroxy vitamin D resistant rickets. In: Norman AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 116–24
90. Ryan EA Reiss E Oncogenous osteomalacia. Am J Med 1984; 77: 501–11
91. Papolous S Clemens TL Fraher LJ Levin IG Sandler LM O'Riordan JLH 1,25 Dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1979; i: 627–30
92. Thomson RB Johnson JK Another family with acute vitamin D intoxication: Another case of familial hypercalcaemia. Postgrad Med J 1986; 62: 1025–8
93. Davies M Adams PH The continuing risk of vitamin D intoxication. Lancet 1978; i: 621–3
94. Paterson CR Vitamin D poisoning: Survey of causes in 21 patients with hypercalcaemia. Lancet 1980; i: 1164–5
95. Howard JE Meyer RJ Intoxication with vitamin D. J Clin Endocrinol 1948; 8: 895–910
96. Mawer EB Hann JT Berry JL Davies M Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci 1985; 68: 135–41
97. Iqbal SJ Taylor WH Treatment of vitamin D2 poisoning by induction of hepatic enzymes. BMJ 1982; 285: 541–2
98. Lukaszkiewicz J Proszynska K Lorenc CR Ludwicza H Hepatic microsomal enzyme induction treatment of vitamin D poisoning in a 7 month old baby. BMJ 1987; 295: 1173
99. Kanis JA Russell RGG Rate of reversal of hypercalcaemia and hypercalcuria induced by vitamin D and its 1 alpha hydroxylated derivative. BMJ 1977; i: 78–81
100. Davies M Hayes ME Mawer EB Lamb GA Abnormal VitD metabolism in Hodgkin's lymphoma. Lancet 1985; ii: 1186–8
101. Prince MJ Shaefer PC Goldsmith RS Chauser AB Hyperphosphatemia, tumoral calcinosis, associated with elevated serum 1,25-dihydroxycholecalciferol concentration. Am J Med 1982; 96: 586–91
102. Editorial. Tumoral calcinosis. Lancet 1987; ii: 1373–4
103. Iqbal SJ Taylor WH Fraher LJ O'Riordan JLH Glutethamide and circulating 1,25 dihydroxyvitamin D in vitamin D intoxication. BMJ 1988; 297: 902–3
104. Hodkinson HJM Hodkinson I Range for 25-hydroxy vitamin D in elderly subjects in whom osteomalacia has been excluded on histological and biochemical criteria. J Clin Exp Gerontol 1980; 2: 133–9
105. Abdul Motadl A Gettinby G McIntosh WB Sutherland GR Dunnigan MG Relationship between radiological and biochemical evidence of rickets in Asian schoolchildren. Postgrad Med J 1985; 61: 307–12
106. Peach H Compston JE Vedi S Horton LWL Value of plasma calcium, phosphate and alkaline phosphatase in diagnosis of histological osteomalacia. J Clin Path 1982; 35: 625–30
107. Hodkinson HM 25-hydroxy vitamin D as a test for osteomalacia. Geriatr Med 1982; 9: 6–7
108. Davie M Lawson DEM Jung RT Low 250H Vitamin D without osteomalacia. Lancet 1978; i: 82
109. Kefetz K Hodkinson HM Osteomalacia in the presence of ‘normal’ serum 25-hydroxycholecalciferol concentration. BMJ 1981; 283: 1437
110. Gupta MM Round JM Stamp TCB Spontaneous cure of vitamin D deficiency in Asians during summer in Britain. Lancet 1974; i: 586–95
111. Mawer BE Clinical implications of measurements of circulating vitamin D metabolite. Clin Endocrinol Metab 1980; 9: 63–79
112. Preece MA Fura JA McIntosh WB Dunnigan MG Tomlinson S O'Riordan JLH VitD deficiency among Asian immigrants to Britain. Lancet 1973; i: 907–10
113. McKenna MJ Freeney R Meade A Muldowney FP Prevention of hypovitaminosis D in the elderly. Calif Tissue Int 1985; 37: 112–16
114. Davies M Mawer EB Hann JT Stephens WP Taylor JL Vitamin D prophylaxis in the elderly: A simple effective method suitable for large populations. Age Ageing 1985; 14: 349–54
115. Dandona P Mohuideen J Weeka Koon JW Freedman DB Fonseca V Heay T Persistence of parathyroid hormone hypersecretion after vitamin D treatment in Asian vegetarians. J Clin Endocrinol Metab 1984; 59: 535–7
116. Stamp TCB Walker PG Perry W Jenkins MV Nutritional osteomalacia and late rickets in Greater London, 1974–1979. Clinical and metabolic studies in 45 patients. J Clin Endocrinol Metab 1980; 9: 81–105
117. Walters MR Kollenkurchen U Fox J The semantics of vitamin D deficiency. In: Norman AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 708–9
118. Corless D Beer M Boucher BJ Gupta SP Cohen RD Vitamin-D status in long-stay geriatric patients. Lancet 1975; i: 1404–6
119. Corless D Gupta SP Satar DA Switala S Boucher BJ Vitamin D status of residents of an old people's home and long-stay patients. Gerontology 1979; 25: 350–5
120. Weisman Y Sehen RJ Eisenberg Z et al. Single oral high-dose vitamin D3 prophylaxis in the elderly. J Am Geriatr Soc 1986; 34: 5–18
121. MacLennan WJ Hamilton JC Vitamin D supplements and 25-hydroxy-vitamin D concentrations in the elderly. BMJ 1977; ii: 859–61
122. Burns J Paterson CR Single dose vitamin D treatment for osteomalacia in the elderly. BMJ 1985; 290: 281–2
123. Bikle DD Gee E Measurement of free vitamin D metabolite levels: biological and clinical significant. In: Norman AW Schaefer K Grigoleit HG Herralt DV, es. Vit D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 703–36
124. Bouillon R Auwerx J Dekeyser L Fevery J Lissens W De Moor P Serum vitamin D metabolites and their binding proteins in patients with liver cirrhosis. J Clin Endocrinol Metab 1984; 59: 86–9
125. Haddad JG Jr Transport of vitamin D and its metabolites. In: Copp DH Talmadge RV, eds. Endocrinology of Calcium Metabolism. Amsterdam: Excerpta Medica, 1978: 186–90
126. Woloszczuk W Determination of vitamin D binding protein by Scatchard analysis and estimation of a free 25-hydroxyvitamin D index. Clin Chim Acta 1985; 145: 27–35
127. Bikle DD Halloran BP Gee E Ryzen E Haddad JG Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986; 78: 748–52
128. Belchetz PE Cohen RD O'Riordan JL Tomlinson S Factitious hypercalcaemia. BMJ 1976; i: 690–1
129. Jibani M Hodges NH Prolonged hypercalcaemia after industrial exposure to vitamin D3. BMJ 1985; 290: 748–9
130. Down PF Polak A Regan RJ A family with massive acute vitamin D intoxication. Postgrad Med J 1979; 55: 89
131. Slatopolsky E Gray R Adams ND Adams J Lewis K et al. Low serum levels of 1,25 dihydroxyvitamin D are not responsible for the development of secondary hyperparathyroidism in early renal failure. Kidney Int 1978; 14: 73–8
132. Ritz E Vitamin D therapy in renal failure— challenges and problems for the future. In: Norman AW Schaefer K Grigoleit HGG Herrath DV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 1027–30
133. Eastwood JB Wardener HE Gray RW Lemann JR Normal plasma 1,25(OH)2 VitD concentration in nutritional osteomalacia. Lancet 1979; i: 1377–8
134. Peacock M Heyburn PJ Aaron J Plasma 1,25(OH)2 VitD concentration in nutritional osteomalacia. Lancet 1979; ii: 195
135. Eisman JA Wark JD Prince RL Moseley JM Modulation of plasma 1,25-dihydroxyvitamin D in man by stimulation and suppression tests. Lancet 1979; ii: 931–2
136. Tsai KS Heath H III Kumar R Riggs BL Impaired vitamin D metabolism with aging in women. J Clin Invest 1984; 73: 1668–72
137. Porteous CE Coldwell RD Trafford DJH Makin HLJ Recent developments in the measurement of vitamin D and its metabolites in human body fluids. J Steroid Biochem 1987; 6: 785–801
138. Seamark DA Trafford DJH Makin HLJ The estimation of vitamin D and its metabolites in human plasma. J Steroid Biochem 1981; 14: 111–23
139. Mayer E Schmidt-Gayk H Interlaboratory comparison of 25-hydroxyvitamin D determination. Clin Chem 1984; 30: 1199–204
140. Carter GD Shunt F 25 hydroxyvitamin D assays: Results of a national quality assessment. J Endocrinol 1988; 117: Suppl. 112
141. Jongen MJM Van Ginkel FC van der Vijgh WJF Kuiper S Netelenbos JC Lips P An international comparison of vitamin D metabolite measurements. Clin Chem 1984; 30: 399–403
142. Monalagas SC Reitz R Hurst R Haddad J Deflos LG Multicentre comparison of 1,25 dihydroxycholecalciferol measurements in human serum. Lancet 1983; i: 191–2
143. Makin HLJ Coldwell RD Trafford DJH Assay for vitamin D and its metabolites: Do we need to improve accuracy and precision? In: Norman AW Bouillon R Thomasset M, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 635–43
144. Carter GD An international external quality assessment scheme for 25 hydroxyvitamin D assays. Comm Lab Med 1992; 3: 130–5